Quest Diagnostics Incorporated v. Elarja

CourtDistrict Court, D. Nevada
DecidedJune 13, 2022
Docket2:22-cv-00647
StatusUnknown

This text of Quest Diagnostics Incorporated v. Elarja (Quest Diagnostics Incorporated v. Elarja) is published on Counsel Stack Legal Research, covering District Court, D. Nevada primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Quest Diagnostics Incorporated v. Elarja, (D. Nev. 2022).

Opinion

1 UNITED STATES DISTRICT COURT

2 DISTRICT OF NEVADA

3 QUEST DIAGNOSTICS INCORPORATED, ) 4 ) Plaintiff, ) Case No.: 2:22-cv-00647-GMN-EJY 5 vs. ) 6 ) ORDER ABDELRAHMAN ELARJA, ) 7 ) Defendant. ) 8 ) 9 10 Pending before the Court is the Amended Motion for Preliminary Injunction, (ECF No. 11 12), filed by Plaintiff Quest Diagnostics, Incorporated (“Plaintiff” or “Quest”). Defendant 12 Abdelrahman Elarja filed a Response, (ECF No. 19), to which Plaintiff filed a Reply, (ECF No. 13 21). 14 For the reasons set forth below, Plaintiff’s Motion for Temporary Restraining Order is 15 GRANTED. 16 I. BACKGROUND 17 This action arises from Abdelrahman Elarja’s (“Defendant’s”) alleged misappropriation 18 of trade secrets and breach of contract while employed at Quest Diagnostics, Inc. (See Verified 19 Compl., ECF No. 1). Plaintiff alleges the following information. 20 A. EMPLOYMENT WITH QUEST 21 Defendant began working with Quest on April 23, 2018, as a Laboratory Supervisor. (Id. 22 ¶ 8). Defendant’s responsibilities included performing advanced or specialized tests, 23 confirming test results, checking and approving all specialized and problem reports for 24 accuracy, and initiating quality control measures when needed. (Id. ¶ 9). Defendant, as part of 25 his employment, entered into an Application Agreement, in which he agreed to “not use or 1 disclose (directly or indirectly) any Confidential Information [. . .] at any time or in any 2 manner, except as required in the course of employment with the Company.” (Id. ¶ 10); (see 3 also Application Agreement, Ex. 1 to Verified Compl., ECF No. 1-1). Confidential 4 Information, as defined by the Application Agreement, includes: 5 information not generally known to the public, including but not limited to trade secrets, patient information, business plans, formulas, technical data, protocols, 6 processes, computer software, customer names, pricing, test results, sales and marketing information and materials, financial information, client information and 7 business methods, plans, policies and practices. If I am unsure whether or not 8 information is confidential, I agree to speak with my manager before disclosing the information. 9 10 (Application Agreement at 1). Defendant also entered into a Confidentiality Agreement, in 11 which he also agreed not to disclose any Confidential Information. (Verified Compl. ¶ 12); (see 12 also Confidentiality Agreement at 3, Ex. 2 to Verified Compl., ECF No. 1-2). 13 On March 23, 2022, Quest’s Data Protection and Governance Department captured an 14 email sent by Defendant from his work server email to his personal email address that included 15 Confidential Information, including Quest’s Standard Operating Procedures (“SOPs”) and 16 training guides. (Verified Compl. ¶ 19). Defendant’s supervisor, Remisola Ajayi, spoke with 17 Defendant to determine why he sent confidential information to his personal account. (Id. ¶ 20). 18 Defendant explained that he sent the information because “he liked to study.” (Id.). As a result 19 of the alleged misappropriation, Quest opened an investigation and discovered that Defendant 20 downloaded a cloud storage program on his work computer. (Id. ¶ 21). On April 2, 2021 and 21 August 19, 2021, Defendant allegedly sent another work email to his personal account on that 22 attached a patient’s test results. (Id. ¶ 22). Plaintiff believes these test results belonged to 23 Defendant’s wife. (Id.). 24 // 25 // 1 On June 8, 2021, Defendant allegedly sent a few emails from his work server email to 2 his personal email concerning another clinical laboratory, Express Medical Labs. (Id. ¶ 23). 3 The emails were titled with information unrelated to the actual emails. (Id.). For example, one 4 email sent on June 8, 2021, included the subject line “lighthouse” but included talking points 5 for Express Medical Labs. (Id.). Specifically, the email states: “Express medical labs strives 6 for excellence in all facilities” and discusses testing and “feedback from experts.” (Id.). 7 From January 9, 2022, to March 23, 2022, Defendant allegedly continued to 8 misappropriate Quest’s SOPs by sending proprietary information to his personal account with 9 misleading and mislabeled subject lines in an attempt to avoid scrutiny from Quest’s Data 10 Protection and Governance Department. (Id. ¶ 27). For example, Defendant allegedly sent an 11 email with the subject line, “Insurance” but attached Quest’s SOP on incident and injury 12 reporting procedures. (Id.). Given Defendant’s prior history with Express Medical Labs, 13 Plaintiff believes Defendant has shared Confidential Information with Express Medical Labs, in 14 violation of the Application Agreement and Confidentiality Agreement. (Id. ¶ 32). As a result 15 of Defendant’s multiple violations, Plaintiff terminated Defendant’s employment on March 29, 16 2022. (Id. ¶ 34). 17 B. POST-EMPLOYMENT WITH QUEST 18 On April 4, 2022, Quest’s counsel sent Defendant a letter requesting the following: 19 (i) provide an accounting for and identify all Quest Confidential Information in his possession; (ii) provide an accounting for and identify all Quest Confidential 20 Information he transmitted to third parties; (iii) return all Quest Confidential Information in his possession; and (iv) allow a third-party IT vendor access to his 21 personal email accounts, devices, and any cloud–based system to identify and delete 22 all Quest Confidential Information. 23 (Id. ¶ 35). The next day, Defendant confirmed that he received the letter, and further revealed 24 that he had been working with Express Medical Labs since April 2021. (Id. ¶ 36). He 25 ultimately agreed to respond to all inquiries by April 6, 2022. (Id.). On April 7, 2022, 1 Defendant sent an email to Quest stating that he deleted the emails he sent to his personal email 2 and that he did not transmit any Confidential Information to any third-party. (Id. ¶ 39). 3 On April 14, 2022, Plaintiff filed the instant suit, alleging the following causes of action: 4 (1) injunctive and equitable relief; (2) breach of contract; (3) breach of the implied covenant of 5 good faith and fair dealing; (4) breach of the duty of loyalty; (5) misappropriation of trade 6 secrets under the Defend Trade Secrets, Act, 18 U.S.C. §§ 1836, et seq.; and (6) 7 misappropriation of trade secrets under the Nevada Uniform Trade Secrets Act, NRS §§ 600A, 8 et seq. (Id. ¶¶ 44–88). Plaintiff simultaneously filed an Emergency Ex Parte Motion for 9 Temporary Restraining Order. (Mot. Temporary Restraining Order, ECF No. 2), which this 10 Court denied. Plaintiff then filed the instant Amended Motion for Preliminary Injunction, (ECF 11 No. 12). 12 II. LEGAL STANDARD 13 The same legal standard applies to both temporary restraining orders and preliminary 14 injunctions sought pursuant to Federal Rule of Civil Procedure 65. See Stuhlbarg Int’l Sales 15 Co. v. John D. Brush & Co., 240 F.3d 832, 839 n.7 (9th Cir. 2001) (noting that the analysis 16 applied to temporary restraining orders and preliminary injunctions is “substantially identical”). 17 A preliminary injunction is “an extraordinary remedy that may only be awarded upon a clear 18 showing that the plaintiff is entitled to such relief.” Winter v. Natural Res. Def. Council, Inc., 19 555 U.S. 7, 24 (2008).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
Quest Diagnostics Incorporated v. Elarja, Counsel Stack Legal Research, https://law.counselstack.com/opinion/quest-diagnostics-incorporated-v-elarja-nvd-2022.